Monthly Archives: May 2017

Cannabis study finds high doses of CBD oil needed for inflammation relief

Regular readers may remember that I have been trying CBD oil for its supposed benefits for inflammation relief. In a previous post, I mentioned that a Medscape article discussed high-dose treatment for autoimmune disorders of 150 mg-600 mg per day.

Posted in Research, Treatment Tagged with: ,

Lamelleye and Lacripep enter clinical trials, adding more eye drop options for Sjogren’s Syndrome patients

Sjogren’s Syndrome patients are experiencing a growing number of options for treating dry eyes. Restasis (Ciclosporin) was the first, and a treatment with which I’ve found some success. Xiidra (Lifitegrast) was approved just last year, and while it is an eye

Posted in Clinical Trials, Treatment Tagged with:
WordPress Appliance - Powered by TurnKey Linux